To say Giacomo Milillo, the national secretary of the Italian Federation of general medicine doctors (Fimmg), at the conclusion of a meeting with the working group on the drug in the national headquarters of the union at Rome, in which is discussed the initiative announced in recent days by the director general of Aifa, Guido Rasi.
For Milillo is an initiative that creates “a great opportunityà of collaboration between the general practitioner and the health Service through the Aifa”.
In particular taking into account the context in which the problem of trasferibilità of the scientific evidence regarding the drug, from research to clinical practice is particularly relevant, and where c’is always less clarity in the theme is most appropriate the prescriptive and sustainabilityà economic – between the role of the national and regional health care.
“it’s a collaboration, intelligently promoted by Rasi – continuous Milillo – what we might consider ‘natural’ and ‘physiological’ for a better fruibilità of the drug, on the part of the citizen, on the issues of appropriateness, security and surveillance of adverse effects, the evaluation of the correct positioning in the therapy of drugs, of the communication”.
Page published on July 16, 2009